164 related articles for article (PubMed ID: 22654590)
1. Prevalence of metabolic syndrome in patients with psoriasis.
Zindancı I; Albayrak O; Kavala M; Kocaturk E; Can B; Sudogan S; Koç M
ScientificWorldJournal; 2012; 2012():312463. PubMed ID: 22654590
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.
Al Mutairi N; Alrqobah D; Haji Hussain N
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29334162
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
[TBL] [Abstract][Full Text] [Related]
4. The role of irisin in the relationship between psoriasis and insulin resistance.
Bulur I; Erdogan HK; Kocatürk E; Saracoglu ZN; Alataş Ö; Yildiz P; Bilgin M
G Ital Dermatol Venereol; 2018 Aug; 153(4):477-482. PubMed ID: 27652568
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing cardiometabolic risk profile in patients with psoriasis.
Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study.
Teklu M; Zhou W; Kapoor P; Patel N; Dey AK; Sorokin AV; Manyak GA; Teague HL; Erb-Alvarez JA; Sajja A; Abdelrahman KM; Reddy AS; Uceda DE; Lateef SS; Shanbhag SM; Scott C; Prakash N; Svirydava M; Parel P; Rodante JA; Keel A; Siegel EL; Chen MY; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
J Am Acad Dermatol; 2021 May; 84(5):1329-1338. PubMed ID: 33383084
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
Adışen E; Uzun S; Erduran F; Gürer MA
An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic syndrome with pediatric psoriasis: a case-control study in Kabul, Afghanistan.
Aalemi AK; Hamdard AG; Chen H
Int J Dermatol; 2020 Apr; 59(4):451-456. PubMed ID: 32043572
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and psoriasis: a study in 97 patients.
Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
[TBL] [Abstract][Full Text] [Related]
10. A Study on the Association of Psoriasis with Metabolic Disorders.
Jadhav N; Nadkarni N; Patil S
J Assoc Physicians India; 2019 Apr; 67(4):52-54. PubMed ID: 31309797
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Diseases and Associated Complications in Patients with Psoriasis.
Bajaj S; Mandal S; Singh KG; Prajapati R
J Assoc Physicians India; 2020 Oct; 68(10):44-46. PubMed ID: 32978925
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis and metabolic syndrome in children: current data.
Pietrzak A; Grywalska E; Walankiewicz M; Lotti T; Roliński J; Myśliński W; Chabros P; Piekarska-Myślińska D; Reich K
Clin Exp Dermatol; 2017 Mar; 42(2):131-136. PubMed ID: 28044372
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis.
Raychaudhuri SK; Chatterjee S; Nguyen C; Kaur M; Jialal I; Raychaudhuri SP
Metab Syndr Relat Disord; 2010 Aug; 8(4):331-4. PubMed ID: 20367239
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance].
Butnoriene J; Norkus A; Bunevicius R; Lasas L
Medicina (Kaunas); 2006; 42(6):455-63. PubMed ID: 16816539
[TBL] [Abstract][Full Text] [Related]
16. Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report.
Brito-Luna MJ; Villanueva-Quintero DG; Sandoval-Talamantes AK; Fafutis-Morris M; Graciano-Machuca O; Sanchez-Hernandez PE; Alvarado-Navarro A
Cytokine; 2016 Sep; 85():130-6. PubMed ID: 27344023
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.
Irimie M; Oanţă A; Irimie CA; Fekete LG; Minea DI; Pascu A
Acta Dermatovenerol Croat; 2015; 23(1):28-35. PubMed ID: 25969910
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis.
Akcali C; Buyukcelik B; Kirtak N; Inaloz S
J Int Med Res; 2014 Apr; 42(2):386-94. PubMed ID: 24445696
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case control study.
Sharma YK; Prakash N; Gupta A
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S72-6. PubMed ID: 26832843
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in a Portuguese obese adolescent population according to three different definitions.
Braga-Tavares H; Fonseca H
Eur J Pediatr; 2010 Aug; 169(8):935-40. PubMed ID: 20177702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
